Isodiol International Inc. (ISOLF)

Market Cap	129.00 -100.0%
Revenue (ttm)	12.18M -18.3%
Net Income	-78.75M
EPS	-1.68
Shares Out	128.53M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	87,878
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0001
Beta	-210.33
RSI	46.65
Earnings Date	n/a

About Isodiol International

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Marcos Agramont
• Employees: 57
• Stock Exchange: OTCMKTS
• Ticker Symbol: ISOLF

Financial Performance

In fiscal year 2019, Isodiol International's revenue was 22.25 million, an increase of 16.26% compared to the previous year's 19.14 million. Losses were -125.91 million, 249.6% more than in 2018.

Financial numbers in CAD